OBJECTIVE. The purpose of the study was to assess metabolic tumor volume and total
glycolytic activity of the primary tumor as prognostic parameters for outcome in patients with …

Objective Metabolic tumor volume (MTV) and total lesion glycolysis (TLG) are imaging
parameters derived from 18F-FDG PET/CT that have been proposed for risk stratification of …

Purpose This study aimed to further stratify prognostic factors in patients with stage IV non-
small cell lung cancer (NSCLC) by measuring their metabolic tumor volume (MTV) using F …

Purpose We evaluated the prognostic impact of volume-based assessment by 18 F-FDG
PET/CT in patients with stage III non-small-cell lung cancer (NSCLC). Methods We reviewed …

Purpose This study aimed to evaluate the prognostic value of metabolic tumor burden as
measured with metabolic tumor volume (MTV) and total lesion glycolysis (TLG), as well as …

Objectives The aim of this study was to evaluate the usefulness of the tumor burden as
characterized by the metabolic tumor volume (MTV) and total lesion glycolysis (TLG) …

Background Patients with advanced non-small cell lung cancer (NSCLC) seem to have
disparity in prognosis. Accurate prediction of prognosis could be useful in the future to …

Purpose Fluorine-18 flurodeoxyglucose positron emission tomography (FDG-PET) imaging
has rapidly become the standard of care for staging patients with lung cancer. We evaluated …

Purpose To determine whether whole-body metabolic tumor burden, measured as either
metabolic tumor volume (MTV WB) or total lesion glycolysis (TLG WB), using FDG-PET/CT is …

Purpose In recent years, multiple studies have demonstrated the value of volumetric FDG-
PET/CT parameters as independent prognostic factors in patients with non-small cell lung …